SHZ · 300298.SZ
Sinocare Inc.
CN¥18.01-CN¥0.12 (-0.66%)
Sinocare Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.37% below the high.
Loading market information…
SHZ · 300206.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Edan Instruments, Inc.’s quoted price sits in the lower half of its reported 52-week range, 29.52% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Edan Instruments, Inc.’s forward annual dividend is CN¥0.31 per share, paid annual. The forward yield is 2.63% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Edan Instruments, Inc.’s next earnings report is currently expected on Apr 1, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Edan Instruments, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Edan Instruments, Inc. is a global provider specializing in the development, manufacturing, and worldwide distribution of a comprehensive range of medical equipment. Their diagnostic electrocardiograph (ECG) portfolio covers a variety of solutions, such as resting ECG, stress testing, Holter monitoring, wireless options, and dedicated ECG workstations. For patient monitoring, Edan offers systems addressing vital signs, transport, central monitoring, and various levels of care—from high acuity to acute and sub-acute settings—along with telemetry and pulse oximetry devices. In the field of obstetrics and gynecology, their offerings include fetal and maternal monitoring systems, fetal telemetry, ultrasonic Doppler devices, and video colposcopes. The company's ultrasound imaging systems encompass both color Doppler and black-and-white digital units. Additionally, Edan provides in-vitro diagnostics (IVD) like hematology analyzers, and a suite of point-of-care testing (POCT) systems, including analyzers for blood gas and chemistry, magnetic immunoassay, and colloidal gold-labeled immunoassay. They also cater to the veterinary market with specialized ultrasound, ECG, ABG, and monitoring products. Edan Instruments, Inc. maintains its headquarters in Shenzhen, People's Republic of China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:38 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥18.01-CN¥0.12 (-0.66%)
Sinocare Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.37% below the high.
CN¥12.44-CN¥0.07 (-0.56%)
Shinva Medical Instrument Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.97% below the high.
CN¥12.46-CN¥0.04 (-0.32%)
Beijing Strong Biotechnologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.37% below the high.
CN¥12.29+CN¥0.17 (+1.4%)
Jiangsu Kanion Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.01% below the high.
CN¥4.34+CN¥0.01 (+0.23%)
Northeast Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.81% below the high.
CN¥40.07-CN¥0.98 (-2.39%)
Xiangyu Medical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 57.82% below the high.
CN¥10.76-CN¥0.49 (-4.36%)
Shenzhen YHLO Biotech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.71% below the high.
CN¥6.02CN¥0.00 (0.0%)
China Animal Husbandry Industry Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.33% below the high.
